title: Tissue swainsonine clearance in sheep chronically poisoned with locoweed (Oxytropis sericea).
abstract: Locoweed poisoning is seen throughout the world and annually costs the livestock industry millions of dollars. Swainsonine inhibits lysosomal alpha-mannosidase and Golgi mannosidase II. Poisoned animals are lethargic, anorexic, emaciated, and have neurologic signs that range from subtle apprehension to seizures. Swainsonine is water-soluble, rapidly absorbed, and likely to be widely distributed in the tissues of poisoned animals. The purpose of this study was to quantify swainsonine in tissues of locoweed-poisoned sheep and determine the rate of swainsonine clearance from animal tissues. Twenty-four crossbred wethers were gavaged with ground Oxytropis sericea to obtain swainsonine doses of 1 mg swainsonine x kg(-1) BW x d(-1) for 30 d. After dosing, the sheep were killed on d 0, 1, 2, 3, 4, 6, 14, 30, 60, and 160. Animal weights and feed consumption were monitored. Serum was collected during dosing and withdrawal periods, and tissues were collected at necropsy. Serum swainsonine concentrations were determined using an alpha-mannosidase inhibition assay. Swainsonine concentrations in skeletal muscle, heart, brain, and serum were similar at approximately 250 ng/g. Clearance from these tissues was also similar, with half-lives (T(1/2)) of less than 20 h. Swainsonine at more than 2,000 ng/g, was detected in the liver, spleen, kidney, and pancreas. Clearance from liver, kidney, and pancreas was about T(1/2) 60 h. These findings imply that poisoned sheep have significant tissue swainsonine concentrations and animals exposed to locoweed should be withheld from slaughter for at least 25 d (10 T(1/2)) to ensure that the locoweed toxin has cleared from animal tissues and products.
authors.affiliation: USDA/ARS Poisonous Plant Research Laboratory, Logan, Utah 84341, USA.
authors.forename: B L
authors.initials: BL
authors.lastname: Stegelmeier
authors.forename: L F
authors.initials: LF
authors.lastname: James
authors.forename: K E
authors.initials: KE
authors.lastname: Panter
authors.forename: D R
authors.initials: DR
authors.lastname: Gardner
authors.forename: M H
authors.initials: MH
authors.lastname: Ralphs
authors.forename: J A
authors.initials: JA
authors.lastname: Pfister
mesh_terms: D000818:Animals; D001835:Body Weight / Q000502:physiology; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry; D006207:Half-Life; D007668:Kidney / Q000737:chemistry / Q000378:metabolism / Q000473:pathology; D008099:Liver / Q000737:chemistry / Q000378:metabolism / Q000473:pathology; D008297:Male; D009132:Muscles / Q000737:chemistry / Q000378:metabolism / Q000473:pathology; D009206:Myocardium / Q000737:chemistry / Q000378:metabolism / Q000473:pathology; D010179:Pancreas / Q000737:chemistry / Q000378:metabolism / Q000473:pathology; D010865:Pilot Projects; D010939:Plant Poisoning / Q000097:blood / Q000378:metabolism / Q000662:veterinary*; D011897:Random Allocation; D012756:Sheep; D012757:Sheep Diseases / Q000097:blood / Q000378:metabolism*; D013154:Spleen / Q000737:chemistry / Q000378:metabolism / Q000473:pathology; D017026:Swainsonine / Q000008:administration & dosage / Q000032:analysis / Q000493:pharmacokinetics*; D013997:Time Factors; D014018:Tissue Distribution
chemical_list: D017026:Swainsonine